Patents by Inventor Carrie A. Kimble

Carrie A. Kimble has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6908744
    Abstract: The disruption of the murine ROR2 gene leads to profound skeletal abnormalities, with essentially all endochondrally derived bones foreshortened and/or misshapen, albeit to differing degrees. ROR2 is selectively expressed in the chondrocytes of all developing cartilage anlagen, where it plays a critical role during initial growth and patterning, as well as subsequently in the proliferating chondrocytes of mature growth plates, where it is required for normal expansion. As ROR2 appears to play a critical role in cartilage formation and it may be useful in developing therapeutic strategies to treat diseases of cartilage such as osteoarthritis.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: June 21, 2005
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Thomas M. DeChiara, Carrie A. Kimble, George D. Yancopoulos, Robert Kimble